Digest Network Come funziona
Network
/
Società
Ta
Non verificato

Takeda Pharmaceutical Company Limited

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

37 comunicati stampa

Guarda tutti i comunicati
07/11/2025
Eventi
Industria
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
03/11/2025
Industria
HIV, AIDS e malattie autoimmuni
Farmaceutica
Salute
Medicina - Varie
New Phase 3 Data Show Takeda’s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
30/10/2025
Biotecnologia
Farmaceutica
Salute
Oncologia
Mercato azionario
Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
27/10/2025
Industria
Attrezzature medico-sanitarie
Igiene alimentare
Medicina - Varie
Biotecnologia
Sanità
Farmaceutica
Salute
Oncologia
HyHub™ and HyHub™ Duo Devices Now Available in the U.S. to Simplify HYQVIA® Infusion Preparation
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
22/10/2025
Mercato del lavoro
Industria
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
23/09/2025
Biotecnologia
Salute
Sanità
Farmaceutica
Associazioni/Professionisti
Ecologia/Salute ambientale
20,000 + Takeda Employees Voted to Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems in 94 Countries
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
16/09/2025
Salute
Nautica/Vela
Logistica
Trasporto e spedizione merci
Farmaceutica
Biotecnologia
Industria
Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
11/09/2025
Takeda Appoints Rhonda Pacheco President of the U.S. Business Unit
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
08/09/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Web e Social Network
Telefonia e Varie
Fiere
Industria
Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
06/09/2025
Biotecnologia
Igiene alimentare
Farmaceutica
Salute
U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0